443
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

, , , , , , , , , & ORCID Icon show all
Article: 2371563 | Received 27 Dec 2023, Accepted 19 Jun 2024, Published online: 24 Jun 2024